关于先锋

Company Profile

Pioneer Information

Notice Announcement

Industry News

Environmental information disclosure

Good news! Good news! Good news!

Release time:

2023-07-10

When the spring of 2023 is approaching, Anhui Pioneer Pharmaceutical Co., Ltd. received the great news that fenofibrate capsules (specification: 0.2g) obtained the consistency evaluation approval.

When the spring of 2023 is approaching, Anhui Pioneer Pharmaceutical Co., Ltd. received the great news that fenofibrate capsules (specification: 0.2g) obtained the consistency evaluation approval.

Back →

Related news

2023-03-08

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

Warmly welcome the entrepreneurs from the 39th class committee of Cheung Kong Graduate School of Business to visit Pioneer Pharmaceutical

2023-02-27

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

Warmly congratulate Pioneer Pharmaceutical Clindamycin Phosphate Injection on obtaining the new approval document, new standard and new Ruijia for generic drug registration!

2023-02-25

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs

Warmly congratulate Anhui Pioneer Pharmaceutical Fenofibrate Capsules for being the first to pass the consistency evaluation of generic drugs